Abstract
Healthcare facilities produce millions of tons of waste annually, with a significant portion consisting of diagnostic plasticware. Here, we introduce a new detection platform that completely replaces traditional assay plates with a piece of membrane, offering a much greener and more sustainable alternative. The membrane, integrated within the portable vortex fluidic device (P-VFD), enables rapid detection of a clinically relevant protein biomarker, urinary p75 ECD. This biomarker is utilized to evaluate the prognosis, disease severity, and progression of amyotrophic lateral sclerosis (ALS). This assay has a limit-of-detection (LOD) of 4.03 pg, which is comparable to the plate-based assay (2.24 pg) and has been optimised through a full factorial design of experiments (DOE) and response surface methodology (RSM). P-VFD has great potential in quantifying p75 ECD in human biofluids and can significantly reduce the assay time to 5 min compared to the current plate-based p75 ECD ELISA assay (3 days), with at least a 4.4-fold reduction in the usage of the detection antibody.
| Original language | English |
|---|---|
| Article number | e202401008 |
| Number of pages | 14 |
| Journal | ChemSusChem |
| Volume | 17 |
| Issue number | 21 |
| Early online date | 10 Jul 2024 |
| DOIs | |
| Publication status | Published - 11 Nov 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 12 Responsible Consumption and Production
Keywords
- Portable Vortex Fluidic Device
- P-VFD
- immunoassay
- biomarker
- ALS
Fingerprint
Dive into the research topics of 'Sustainability-Driven Accelerated Shear-Mediated Immunoassay for Amyotrophic Lateral Sclerosis Detection'. Together they form a unique fingerprint.Equipment
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver